CMMB
Chemomab Therapeutics Ltd.
There isn't enough reported data to score CMMB yet.
CMMB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
CMMB's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
CMMB PE Valuation
CMMB has no meaningful PE right now: it lost money over the past year.
CMMB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect CMMB's losses to shrink, with revenue holding steady.
CMMB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.02 | +$1.35 |
CMMB is still losing money, but far less than before: $1.02 per share over the past year, against $2.37 at its worst in mid-2025.
CMMB Quarterly Revenue
CMMB's revenue is shrinking: $0 last quarter.
CMMB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | -$11.2M | -$11.2M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | +$3.9M |
| Q3 2024 | $0 | +$5.1M |
CMMB has burned cash in most quarters: −$11M over the past year, against $0 the year before.
CMMB Net Leverage
CMMB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CMMB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.3 | Neutral |
| Stochastic | 18.0 | Oversold |
CMMB's weekly RSI is 43 (neutral) and its Stochastic is 18 (oversold).
CMMB PE vs Healthcare Sector
CMMB has no meaningful PE right now: it lost money over the past year.
CMMB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.39 | 0.7% above |
| 20 week MA | $1.81 | 23% below |
| 50 week MA | $1.77 | 21% below |
| 100 week MA | $3.34 | 58% below |
| 200 week MA | $4.03 | 65% below |
CMMB has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 65% below its 200-week average.
CMMB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $90.9 | $141.4 | +56% |
| 2021 | $141.4 | $30.2 | -79% |
| 2022 | $30.2 | $9.44 | -69% |
| 2023 | $9.44 | $2.04 | -78% |
| 2024 | $2.04 | $8.04 | +294% |
| 2025 | $8.04 | $1.80 | -78% |
| 2026 YTD | $1.80 | $1.40 | -22% |
CMMB's yearly returns have swung widely, from +294% in 2024 to −79% in 2021. It's down 22% so far in 2026.